Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024
Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024
Truist Securities維持對Tenet Healthcare的買入,將目標股價上調至105美元,於2024年2月8日發佈的報告
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $92 to $105.
Truist Securities分析師戴維·麥克唐納維持Tenet Healthcare(紐約證券交易所代碼:THC)的買入並將目標股價從92美元上調至105美元。